Zomedica's Total Assets for the quarter that ended in Mar. 2024 was $243.70 Mil.
During the past 12 months, Zomedica's average Total Assets Growth Rate was 1.40% per year.
During the past 3 years, the average Total Assets Growth Rate was 239.70% per year.
During the past 5 years, the average Total Assets Growth Rate was 155.60% per year.
During the past 11 years, Zomedica's highest 3-Year average Total Assets Growth Rate was 1169.70%. The lowest was 32.90%. And the median was 247.45%.
Total Assets is connected with ROA %. Zomedica's annualizedROA % for the quarter that ended in Mar. 2024 was -14.75%. Total Assets is also linked to Revenue through Asset Turnover. Zomedica's Asset Turnover for the quarter that ended in Mar. 2024 was 0.03.
Zomedica Total Assets Historical Data
The historical data trend for Zomedica's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Zomedica's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Zomedica's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Zomedica Total Assets Related Terms
Thank you for viewing the detailed overview of Zomedica's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZOM has been successfully added to your 